PATENT CLAIM ANALYSIS

Application Number: 16090142
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-04
Patent Classification: ["514", "250000"]

Abstract:
The invention provides methods for the prophylaxis or treatment of one or more disorders associated with dementia comprising administering to a patient in need thereof, a therapeutically effective amount of (i) a 5-HT2A or 5-HT2A/D2 receptor ligand and (ii) a PDE1 inhibitor, and pharmaceutical compositions comprising (i) a 5-HT2A or 5-HT2A/D2 receptor ligand and (ii) a PDE1 inhibitor.

Claim (Index 17):
The pharmaceutical composition of  claim 16  wherein the 5-HT2A or 5-HT2A/D2 receptor ligand is a compound of Formula I: wherein: X is \u2014N(H)\u2014, \u2014N(CH 3 )\u2014 or \u2014O\u2014; Y is \u2014C(\u2550O), \u2014C(H)(OH) or \u2014C(H)(OR 1 ); R 1  is \u2014C(O)\u2014C 1-21 alkyl, optionally saturated or unsaturated and optionally substituted with one or more hydroxy or C 1-22 alkoxy groups, wherein such compound hydrolyzes to form the residue of a natural or unnatural, saturated or unsaturated fatty acid, tetradecanoic acid or hexadecanoic acid on the other hand), in free, pharmaceutically acceptable salt or prodrug form.

Metadata:
- Claim Count in Document: 68.0
- Percentile: 97.0
- Lexical Diversity: 1.64286
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14399334', '15977166', '14885813', '14066987', '14409866']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7944293239512061
- 35 USC 102 Novelty (BERT): 0.5062870460176249
- Combined Prediction Score: 0.7656150961578481
- Mean Citation Score: 271.499892
- Max Citation Score: 273.0258
- Similarity Product: 203.9570041445017

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test